Lexaria Bioscience Corp. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 460.00 K | $966.00 K | 100.00% | 2.76% |
| INVENOMIC CAPITAL MANAGEMENT LP | 02/14/2025 | 410.73 K | $862.54 K | -13.67% | 2.46% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 166.68 K | $350.11 K | 10.83% | 1.00% |
| VANGUARD GROUP INC | 02/11/2025 | 127.43 K | $267.61 K | 16.89% | 0.76% |
| RAYMOND JAMES FINANCIAL INC | 04/23/2025 | 60.64 K | $127.34 K | 100.00% | 0.36% |
| STATE STREET CORP | 02/14/2025 | 39.30 K | $82.53 K | 0.00% | 0.24% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 03/17/2025 | 28.87 K | $60.63 K | 108.88% | 0.17% |
| BLACKROCK, INC. | 02/07/2025 | 27.45 K | $57.64 K | 0.00% | 0.16% |
| HIGHTOWER ADVISORS, LLC | 02/07/2025 | 21.02 K | $44.15 K | 61.43% | 0.13% |
| MORGAN STANLEY | 02/14/2025 | 20.23 K | $42.48 K | -11.98% | 0.12% |
| NORTHERN TRUST CORP | 02/14/2025 | 18.39 K | $38.62 K | 0.00% | 0.11% |
| BANK OF MONTREAL /CAN/ | 02/13/2025 | 14.00 K | $29.40 K | 0.00% | 0.08% |
| BYRNE ASSET MANAGEMENT LLC | 01/28/2025 | 13.00 K | $27.30 K | 132.14% | 0.08% |
| SCOTIA CAPITAL INC. | 02/13/2025 | 10.00 K | $21.00 K | 100.00% | 0.06% |
| ROYAL BANK OF CANADA | 02/14/2025 | 7.28 K | $15.00 K | 0.00% | 0.04% |
| OAKWORTH CAPITAL, INC. | 01/27/2025 | 5.00 K | $10.50 K | 0.00% | 0.03% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 4.00 K | $8.40 K | 60.00% | 0.02% |
| 01/23/2025 | 2.62 K | $5.50 K | 100.00% | 0.02% | |
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 2.29 K | $6.51 K | 0.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 2.08 K | $4.37 K | 54.91% | 0.01% |
| FARTHER FINANCE ADVISORS, LLC | 02/10/2025 | 166 | $349 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 126 | $265 | 9.57% | 0.00% |
| UBS GROUP AG | 02/14/2025 | 116 | $244 | 100.00% | 0.00% |
| SOUND INCOME STRATEGIES, LLC | 01/21/2025 | 22 | $47 | 0.00% | 0.00% |
| GABLES CAPITAL MANAGEMENT INC. | 02/07/2025 | 13 | $27 | 0.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| WELCH GROUP, LLC | 01/27/2025 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GENTRUST, LLC | 02/05/2025 | 0 | $0 | -100.00% | 0.00% |
| ASPIRE PRIVATE CAPITAL, LLC | 01/17/2025 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Lexaria Bioscience Corp. institutional Ownership - FAQ's
During the previous two years, 24 institutional investors and hedge funds held shares of Lexaria Bioscience Corp.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 460,000
Invenomic Capital Management LP: 410,731
GEODE CAPITAL MANAGEMENT, LLC: 166,679
VANGUARD GROUP INC: 127,433
RAYMOND JAMES FINANCIAL INC: 60,640
STATE STREET CORP: 39,301
8.65% of Lexaria Bioscience Corp. stock is owned by institutional investors.
Institutional investors have bought a total of 1.44 M shares in the last 24 months. This purchase volume represents approximately $1.71 M in transactions.